News
Purpose Adenoid hypertrophy (AH) is common among young children. Adenoid-based surgery and drug therapy could be applied for symptomatic AH patients, yet the treatment decision is difficult to make ...
We constructed a decision model with a 10-year time horizon. The seven treatment drug strategies included atezolizumab + bevacizumab, avelumab + axitinib, pembrolizumab + axitinib, nivolumab + ...
To assess the cost-effectiveness of injectable bone cement augmentation (Traumacem V+, DePuy Synthes) vs. no augmentation for the fixation of unstable trochanteric fractures, Christian Kammerlander, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results